On Invalid Date, Immix Biopharma (NASDAQ: IMMX) reported Q4 2023 earnings per share (EPS) of -$0.24, up 11.11% year over year. Total Immix Biopharma earnings for the quarter were -$5.09 million. In the same quarter last year, Immix Biopharma's earnings per share (EPS) was -$0.27.
As of Q2 2024, Immix Biopharma's earnings has grown year over year. Immix Biopharma's earnings in the past year totalled -$15.43 million.
What was IMMX's revenue last quarter?
On Invalid Date, Immix Biopharma (NASDAQ: IMMX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Immix Biopharma's revenue was $0.00.
What was IMMX's revenue growth in the past year?
As of Q2 2024, Immix Biopharma's revenue has grown null year over year. Immix Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.